Literature DB >> 19930276

Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex.

P Costa1, A Amaro, A Botelho, J Inácio, P V Baptista.   

Abstract

Members of the Mycobacterium tuberculosis complex (MTC) are causative agents of human and animal tuberculosis. This complex encompasses several phylogenetically related species, including M. tuberculosis, the main aetiological agent of human tuberculosis, and Mycobacterium bovis, the causative agent of bovine tuberculosis, a relevant worldwide zoonosis. Clear epidemiological evaluation of appropriate and effective treatment requires unambiguous differentiation between MTC members. Routine diagnosis has been increasingly relying on the molecular identification of MTC members. In the present study, we report the use of a gold nanoparticle-based approach for the sensitive, specific and fast identification of MTC and for the differentiation of M. bovis and M. tuberculosis using the gyrB locus as target. This gold nanoprobe strategy relies on the colorimetric differentiation of specific DNA sequences based on differential aggregation profiles in the presence or absence of specific target hybridization. Three nanoprobes were designed and successfully used for the specific identification of members of MTC, M. bovis and M. tuberculosis.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19930276     DOI: 10.1111/j.1469-0691.2009.03120.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Label free fluorometric characterization of DNA interaction with cholate capped gold nanoparticles using ethidium bromide as a fluorescent probe.

Authors:  Gunasekaran Dharanivasan; Denison Michael Immanuel Jesse; Shanmugam Chandirasekar; Nagappan Rajendiran; Krishnan Kathiravan
Journal:  J Fluoresc       Date:  2014-06-20       Impact factor: 2.217

2.  RNA quantification using gold nanoprobes - application to cancer diagnostics.

Authors:  João Conde; Jesús M de la Fuente; Pedro V Baptista
Journal:  J Nanobiotechnology       Date:  2010-02-24       Impact factor: 10.435

Review 3.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Authors:  ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Biotechnol Adv       Date:  2013-01-26       Impact factor: 14.227

4.  Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis.

Authors:  Bruno Veigas; Pedro Pedrosa; Isabel Couto; Miguel Viveiros; Pedro V Baptista
Journal:  J Nanobiotechnology       Date:  2013-11-25       Impact factor: 10.435

Review 5.  Noble metal nanoparticles for biosensing applications.

Authors:  Gonçalo Doria; João Conde; Bruno Veigas; Leticia Giestas; Carina Almeida; Maria Assunção; João Rosa; Pedro V Baptista
Journal:  Sensors (Basel)       Date:  2012-02-07       Impact factor: 3.576

Review 6.  Standing of nucleic acid testing strategies in veterinary diagnosis laboratories to uncover Mycobacterium tuberculosis complex members.

Authors:  Pedro Costa; Ana Botelho; Isabel Couto; Miguel Viveiros; João Inácio
Journal:  Front Mol Biosci       Date:  2014-10-15

7.  Paper-based tuberculosis diagnostic devices with colorimetric gold nanoparticles.

Authors:  Tsung-Ting Tsai; Shu-Wei Shen; Chao-Min Cheng; Chien-Fu Chen
Journal:  Sci Technol Adv Mater       Date:  2013-08-06       Impact factor: 8.090

8.  Enhanced detection of tuberculous mycobacteria in animal tissues using a semi-nested probe-based real-time PCR.

Authors:  Pedro Costa; Ana S Ferreira; Ana Amaro; Teresa Albuquerque; Ana Botelho; Isabel Couto; Mónica V Cunha; Miguel Viveiros; João Inácio
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

Review 9.  AuNPs for identification of molecular signatures of resistance.

Authors:  Bruno Veigas; Alexandra R Fernandes; Pedro V Baptista
Journal:  Front Microbiol       Date:  2014-08-28       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.